Dolasetron 10-mg/mL Oral Liquid
Download in electronic PDF format for $65
Abstract: A formulation for preparing Dolasetron 10-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.
Related Keywords:
Loyd V. Allen Jr, PhD, RPh, formulations, liquid preparations, dolasetron, vomiting, prevention, antiemetic agent, 5-HT3 receptor inhibitor
Related Categories:
CANCER AND AIDS, FORMULATIONS, GASTROENTEROLOGY, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Dolasetron 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 475
|
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 449-450
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
Granisetron 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 66
|
Ondansetron Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 339
|
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 419
|
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 513
|
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
|
Nov/Dec 2014
Pg. 520-525
|
Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 510
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Jul/Aug 2014
Pg. 278-286
|
